key: cord-0957853-8j49btgc
authors: Ahammed, Tanvir; Anjum, Aniqua; Rahman, Mohammad Meshbahur; Haider, Najmul; Kock, Richard; Uddin, Md Jamal
title: Estimation of novel coronavirus (COVID‐19) reproduction number and case fatality rate: A systematic review and meta‐analysis
date: 2021-05-03
journal: Health Sci Rep
DOI: 10.1002/hsr2.274
sha: 1a62c15769d132ae1598b01c9480be180d782e9f
doc_id: 957853
cord_uid: 8j49btgc

BACKGROUND AND AIMS: Realizing the transmission potential and the magnitude of the coronavirus disease 2019 (COVID‐19) aids public health monitoring, strategies, and preparation. Two fundamental parameters, the basic reproduction number (R (0)) and case fatality rate (CFR) of COVID‐19, help in this understanding process. The objective of this study was to estimate the R (0) and CFR of COVID‐19 and assess whether the parameters vary in different regions of the world. METHODS: We carried out a systematic review to find the reported estimates of the R (0) and the CFR in articles from international databases between January 1 and August 31, 2020. Random‐effect models and Forest plots were implemented to evaluate the mean effect size of R (0) and the CFR. Furthermore, R (0) and CFR of the studies were quantified based on geographic location, the tests/thousand population, and the median population age of the countries where the studies were conducted. To assess statistical heterogeneity among the selected articles, the I (2) statistic and the Cochran's Q test were used. RESULTS: Forty‐five studies involving R (0) and 34 studies involving CFR were included. The pooled estimation of R (0) was 2.69 (95% CI: 2.40, 2.98), and that of the CFR was 2.67 (2.25, 3.13). The CFR in different regions of the world varied significantly, from 2.49 (2.08, 2.94) in Asia to 3.40 (2.81, 4.04) in North America. We observed higher mean CFR values for the countries with lower tests (3.15 vs 2.16) and greater median population age (3.13 vs 2.27). However, R (0) did not vary significantly in different regions of the world. CONCLUSIONS: An R (0) of 2.69 and a CFR of 2.67 indicate the severity of the COVID‐19. Although R (0) and CFR may vary over time, space, and demographics, we recommend considering these figures in control and prevention measures.

Since the emergence of SARS-CoV-2, the virus causing COVID-19, in late 2019, there have been more than 35 million confirmed cases, and 950 000 confirmed deaths have been reported as of September 19 , 2020. 1 The basic reproduction number (R 0 ) determines a disease's transmission potential and can be used to inform public health policies. In a susceptible population, the expected number of cases generated by one infected case is specified as R 0.

2,3 Outbreaks will continue to propagate until this number falls below 1.0. A timely and accurate assessment of COVID-19's R 0 notifies COVID is of great significance for assessing the spread of the virus, predicting future trends, and adjusting a series of control measures.

Another important factor to inform is the case fatality rate (CFR), which is the proportion of patients who die from a specified disease compared with the total number of patients identified with the disease within a defined population of interest and is typically presented as a percentage. 4 CFR is an indicator of disease severity and can be used to identify high-risk populations to inform targeted interventions and the overall public health response. 5 To understand the transmissibility and severity of SARS-CoV-2 in populations, there have been several estimates of R 0 and the CFR.

Estimates of R 0 and CFR have varied in different countries and different settings. 6 For example, in the Diamond Princess cruise ship, the estimated median R 0 was 2.28 (95% CI: 2.06-2.52). 7 At the early stages of the epidemic in Wuhan, the value of R 0 was estimated as 2.24 (95% CI: 1.96-2.55). 8 R 0 has also been estimated for several other countries, including Italy, 3.2 (95% CI: 2.9-3.5) 9 ; USA, 5.3 (95% CI: 4.35-6.25) 10 ; and, Japan, 2.6 (95% CI: 2.4-2.8). 11 Likewise, the estimates of CFRs have varied in different countries and phases of the pandemic. A study found that, at the start of the epidemic, CFR in China was 2%, but on March 5, 2020, it increased to 3.7%.

In South Korea, the same study reported the CFR as 0.6% on March 5, 2020. 12 In Europe, during March 2020, Italy, Spain, and France had a CFR of 9.26%, 6.16%, and 4.21%, respectively. 13 Given the considerable variation in estimates of both these parameters, in this current study, our aim was to perform a systematic review and meta-analysis of the published studies on the COVID-19 outbreak to provide summary statistics of R 0 and the CFR that are most applicable to other countries or regions.

We followed the Preferred Reporting Items for Systematic Review and Meta-Analysis Protocols (PRISMA-P) 2009. The protocol of the study was registered with the International prospective register of systematic reviews (PROSPERO) (registration number ID: CRD42020182867).

We systematically searched the major databases: LitCovid (a curated COVID-19 database of PubMed), PubMed, EMBASE, Scopus, and Web of Science from January 1 to August 31, 2020.

We searched articles for "Basic reproduction number (R 0 )" and "Case-fatality rate (CFR)" of the COVID-19 patients. For basic reproduction number, the search terms were as follows: "2019 novel coronavirus and COVID-19" AND "Basic reproduction number", OR "Basic reproduction rate" OR "R 0 ." For the case fatality rate, the search terms were "2019 novel coronavirus and COVID-19" AND "case fatality rate," OR "case fatality ratio," OR "CFR"

according to the indices of the various databases (Table S1) . We also manually scanned the reference lists of the included articles and consulted specialists in the field to ensure a thorough analysis.

The records were managed by Mendeley version 1.19.4 software to exclude duplicates.

Articles were selected if they reported CFR and/or R0 with a con- 

After excluding duplicate papers, two investigators (TA and AA) independently evaluated the full-text articles for inclusion after screening the titles and abstracts using the eligibility criterion. 

The critical appraisal of each selected study was assessed by TA and AA independently using modified risk-of-bias (ROB) operational criteria (Tables S2 and S3 ). 86 A funnel plot was used to determine publication bias, and an Egger's test with P < .05 was an indication of small-study effects.

We defined R 0 as the number of expected cases directly generated by one infected case in a susceptible population and CFR as the percent- 

We identified a total of 490 articles estimating R 0 . After considering the duplicates, inclusion, and exclusion criteria, we reviewed these research articles. We searched for titles, abstracts and keywords, methodology, and references and found 59 articles to investigate further ( Figure 1 ). Out of these 59 articles, we found 45 research articles that reported 108 R 0 estimates ranging from 0.27 to 8.21

with related statistics for a meta-analysis (Table S4) (Table S5) .

No studies were excluded.

The 

The pooled estimation of the CFR from the random-effects model was 2.67 (2.25, 3.13). There was significant heterogeneity between studies (I 2 : 99.95, Q = 315 324.53 with P = .00; Table 2 , and Figure 4 ).

The high value of the I 2 statistic (99.95%) confirms a high level of between-study heterogeneity. 

According to our estimation of the R 0 statistic, in the absence of any control measures, one infected individual can transmit the infection to more than two and a half susceptible persons in a naïve population.

However, R 0 did not significantly differ across the continents. Among these regions, the highest R 0 was estimated for "North America"

(3.69) and the lowest for "Asia" (2.56). We estimated a CFR of above severe acute respiratory syndrome epidemic (9.6%), and the Middle East respiratory syndrome (40%), 90 but higher than that of influenza (0Á1%). 93, 94 Although several researchers found higher case fatality rates than ours, usually those are not the actual case fatality rates, as mild, atypical, and asymptomatic cases may not be identified (contrary to deaths), particularly in countries where access to testing is limited. 95 For example, before March 11, 2020 in United States, there was insufficient state-funded testing. 96 According to a study of 565 Wuhan evacuated Japanese citizens, the CFR would then only be around one-tenth of what it is now if we consider the underreporting. 97 Our included studies may suffer from underreporting bias, which could increase the pooled CFR estimation.

Thus, we further estimated the CFR by excluding the extreme values and the naive CFR greater than four. These gave us lower CFR values close to one.

In our estimation, the CFR varied among different regions, but R 0 did not vary significantly. We found lower CFR in the countries with a higher number of sample testing per thousand population. A higher number of testing allowed the detection of more pre-/a-symptomatic and mild cases, which reduced the rate of fatal outcomes. 98 We further found that countries with higher median age had higher CFR values. Older age has been recognized as one of the most common risk factors for a severe outcome of COVID-19. 99-101 A study conducted with 5484 patients in Italy found the CFR of COVID-19 was 0.43% for people below 70 years and 10.5% for people aged 70 years and above. 101 Another study showed that an increase of 1% population that is aged 65 years and above increased the risk of death due to COVID-19 by 10%. 100 An estimate of R 0 is affected by several factors, including the proportion of the susceptible population, population density, and 

An important limitation of our study was that very few studies on Africa (one article on CFR and three articles on R 0 ), South America (two articles on R 0 ), and Oceania (four articles on CFR) were available in peer-reviewed journals. Therefore, our estimated R 0 and CFR estimates for these regions might not be representative. Thus, we were unable to draw any conclusion on CFR or R 0 of these geographical regions. Furthermore, we did not include any preprint articles, although 

The authors declare there is no conflict of interest. Md. Jamal Uddin had full access to all of the data in this study and takes complete responsibility for the integrity of the data and the accuracy of the data analysis.

Tanvir Ahammed affirms that this manuscript is an honest, accurate, and transparent account of the study being reported; that no important aspects of the study have been omitted; and that any discrepancies from the study as planned (and, if relevant, registered) have been explained.

The complete list of data and the data entries for all included studies are provided in the paper (Tables S4 and S5) 

COVID-19 coronavirus pandemic

Pandemic potential of a strain of influenza a (H1N1): early findings

The reproduction number

Mortality: statistics

Estimating absolute and relative case fatality ratios from infectious disease surveillance data

Analysis and forecast of COVID-19 spreading in China, Italy and France

Estimation of the reproductive number of novel coronavirus (COVID-19) and the probable outbreak size on the Diamond Princess cruise ship: a datadriven analysis

Preliminary estimation of the basic reproduction number of novel coronavirus (2019-nCoV) in China, from 2019 to 2020: a data-driven analysis in the early phase of the outbreak

Preliminary estimates of the reproduction number of the coronavirus disease (COVID-19) outbreak in Republic of Korea and Italy by March 5, 2020

Outbreak dynamics of COVID-19 in China and the United States

Prediction of the epidemic peak of coronavirus disease in Japan

Is coronavirus disease (COVID-19) case fatality ratio underestimated?

Cross-country comparison of case fatality rates of COVID-19/SARS-COV-2. Osong Public Heal Res Perspect

Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia

Pattern of early human-to-human transmission of Wuhan

Tracing day-zero and forecasting the COVID-19 outbreak in Lombardy, Italy: A compartmental modelling and numerical optimization approach

High contagiousness and rapid spread of severe acute respiratory syndrome coronavirus 2

Transmission potential and severity of COVID-19 in South Korea

The effectiveness of quarantine and isolation determine the trend of the COVID-19 epidemics in the final phase of the current outbreak in China

Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study

Estimating the unreported number of novel coronavirus (2019-nCoV) cases in China in the first half of January 2020: a data-driven modelling analysis of the early outbreak

On a statistical transmission model in analysis of the early phase of COVID-19 outbreak

Imitation dynamics in the mitigation of the novel coronavirus disease (COVID-19) outbreak in Wuhan

The role of asymptomatic class, quarantine and isolation in the transmission of COVID-19

Estimation of incubation period and generation time based on observed length-biased epidemic cohort with censoring for COVID-19 outbreak in China

Risk estimation of the SARS-CoV-2 acute respiratory disease outbreak outside China

Estimation of unreported novel coronavirus (SARS-CoV-2) infections from reported deaths: a susceptible-exposed-infectious-recovered-dead model

Effect of a wet market on coronavirus disease (COVID-19) transmission dynamics in China

Transmission dynamics and control strategies of COVID-19 in Wuhan

When will the battle against novel coronavirus end in Wuhan: a SEIR modeling analysis

Current trends and future prediction of novel coronavirus disease (COVID-19) epidemic in China: a dynamical modeling analysis

Estimating the serial interval of the novel coronavirus disease (COVID-19) based on the public surveillance data in

Extended SIR prediction of the epidemics trend of COVID-19 in Italy and compared with Hunan

Evaluating transmission heterogeneity and super-spreading event of COVID-19 in a Metropolis of China

Analysis of the transmissibility change of 2019-novel coronavirus pneumonia and its potential factors in China from 2019 to 2020

Forecast possible risk for COVID-19 epidemic dissemination under current control strategies in Japan

The basic reproduction number and prediction of the epidemic size of the novel coronavirus (COVID-19) in Shahroud

Impact of nonpharmacological interventions on COVID-19 transmission dynamics in India

Assessment of lockdown effect in some states and overall india: A predictive mathematical study on covid-19 outbreak

Estimation of reproduction numbers of COVID-19 in typical countries and epidemic trends under different prevention and control scenarios

Is Nigeria really on top of COVID-19? Message from effective reproduction number

Epidemiological and clinical characteristics of the COVID-19 epidemic in Brazil

Impact of lockdown on COVID-19 epidemic in Île-de-France and possible exit strategies

Early transmission dynamics of novel coronavirus (COVID-19) in Nigeria

Phase-adjusted estimation of the COVID-19 outbreak in South Korea under multi-source data and adjustment measures: a modelling study

Modelling the effects of media coverage and quarantine on the COVID-19 infections in the UK

The reproduction number of COVID-19 and its correlation with public health interventions

Estimates of the ongoing need for social distancing and control measures post-"lockdown" from trajectories of COVID-19 cases and mortality

Early transmission dynamics of COVID-19 in a southern hemisphere setting

Data-based analysis, modelling and forecasting of the COVID-19 outbreak

Risk assessment of novel coronavirus COVID-19 outbreaks outside China

Estimating the reproductive number and the outbreak size of COVID-19 in Korea

Real-time estimation of the risk of death from novel coronavirus (COVID-19) infection: inference using exported cases

Early dynamics of transmission and control of COVID-19: a mathematical modelling study

Estimating risk for death from coronavirus disease, China

Case fatality rate estimation of COVID-19 for European countries: Turkey's current scenario amidst a global pandemic; comparison of outbreaks with European countries

Similarity in case fatality rates (CFR) of COVID-19/SARS-COV-2 in Italy and China

Estimating the infection and case fatality ratio for coronavirus disease (COVID-19) using ageadjusted data from the outbreak on the Diamond Princess cruise ship

Estimates of the severity of coronavirus disease 2019: a model-based analysis

Early estimation of the case fatality rate of COVID-19 in mainland China: a data-driven analysis

Monitoring transmissibility and mortality of COVID-19 in Europe

Epidemic trend of COVID-19 transmission in India during Lockdown-1 phase

Epidemiological characteristics and forecast of COVID-19 outbreak in the Republic of Kazakhstan

Global epidemiology of first 90 days into COVID-19 pandemic: disease incidence, prevalence, case fatality rate and their association with population density, urbanisation and elderly population

COVID-19 trends and forecast in the eastern Mediterranean region with a particular focus on Pakistan

Case fatality risk of the first pandemic wave of novel coronavirus disease 2019 (COVID-19) in China

The epidemiology of COVID-19 cases and the successful containment strategy in Hong Kong

Temporal estimates of case-fatality rate for COVID-19 outbreaks in Canada and the United States

Risk of Death by Age and Gender from CoVID-19 in Peru

Is Colombia an example of successful containment of the COVID-19 2020 pandemic? A critical analysis of the epidemiological data

Impact of comorbidities in MEXICAN SARS-COV-2-positive patients: a retrospective analysis in a national cohort

Estimation of SARS-CoV-2 mortality during the early stages of an epidemic: a modeling study in Hubei, China, and six regions in Europe

High altitude reduces infection rate of COVID-19 but not case-fatality rate

Age-dependent gender differences of COVID-19 in mainland China: comparative study

COVID-19 in a designated infectious diseases hospital outside Hubei Province

Estimating the risk of COVID-19 death during the course of the outbreak in Korea

Epidemiology of the 2020 pandemic of COVID-19 in the State of Texas: the first month of community spread

Role of environmental temperature on the attack rate and case fatality rate of coronavirus disease 2019 (COVID-19) pandemic

Epidemiology of COVID-19 infection in Oman: analysis of the first 1304 cases

Understanding epidemic data and statistics: a case study of COVID-19

Analysis of heart injury laboratory parameters in 273 COVID-19 patients in one hospital in Wuhan

First-wave COVID-19 transmissibility and severity in China outside Hubei after control measures, and second-wave scenario planning: a modelling impact assessment

Preparedness is essential for Western Pacific Islands during the COVID-19 pandemic

Estimating the instant case fatality rate of COVID-19 in China

Preliminary estimate of COVID-19 case fatality rate in The Philippines using linear regression analysis

Assessing risk of bias in prevalence studies: modification of an existing tool and evidence of interrater agreement

The reproductive number of COVID-19 is higher compared to SARS coronavirus

Estimation of the basic reproduction number, average incubation time, asymptomatic infection rate, and case fatality rate for COVID-19: meta-analysis and sensitivity analysis

Estimate of the basic reproduction number for COVID-19: a systematic review and meta-analysis

The Lancet Infectious Diseases. MERS-an uncertain future

Epidemiology Working Group for NCIP Epidemic Response Chinese Center for Disease Control and Prevention. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China

WHO Director-General's opening remarks at the media briefing on COVID-19 -3

SARS and MERS: recent insights into emerging coronaviruses

Covid-19 -navigating the uncharted

COVID-19: Where's the Evidence?

The rate of under ascertainment of novel coronavirus (2019-nCoV) infection: estimation using Japanese passengers data on evacuation flights

Covid-19 mortality is negatively associated with test number and government effectiveness

COVID-19 mortality increases with northerly latitude after adjustment for age suggesting a link with ultraviolet and vitamin D

The Global Health security index and joint external evaluation score for health preparedness are not correlated with countries' COVID-19 detection response time and mortality outcome

Age-specific SARS-CoV-2 infection fatality ratio and associated risk factors, Italy

Will Coronavirus Pandemic Diminish by Summer?

Vitamin D: A simpler alternative to tocilizumab for trial in COVID-19? Med Hypotheses

Seasonal immunity: Activity of thousands of genes differs from winter to summer

Impact of climate and public health interventions on the COVID-19 pandemic: a prospective cohort study

Estimation of novel coronavirus (COVID-19) reproduction number and case fatality rate: A systematic review and meta-analysis